Increased mortality from somatic multimorbidity in patients with schizophrenia: A Danish nationwide cohort study
Acta Psychiatrica Scandinavica Oct 11, 2019
Kugathasan P, et al. - In patients with schizophrenia (n = 30,210; mean age {SD} was 32.6 {11.4}) vs the general population (n = 5,402,611; mean age {SD} was 33.0 {14.5}), researchers examined the correlation of single- and multimorbidity with mortality rates. According to results, schizophrenia patients reported higher mortality at all multimorbidity levels and doubled mortality rates across all somatic diseases [ie, infections, cancer, endocrine, neurologic, cardiovascular, respiratory, digestive, skin, musculoskeletal, and urogenital diseases] vs the general population. The findings suggest that the main driver of excess mortality is the clusters and trajectories of symptoms associated with schizophrenia.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries